2m 2m 2m 2m 2m 2m 2m
BEAM THERAPEUTIC (BEAM)
NASDAQ
$26.01+$0.49 (+1.94%)
Price as of Aug 03, 2026 7:19 AM EDT- $2.6BMarket Cap
- 35.53%1-Year Change
- BiotechnologyIndustry
BEAM THERAPEUTIC (BEAM)
$26.01+$0.49 (+1.94%)
BEAM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $25.52 | ||
Change | -$0.97 (-3.66%) | ||
Open | $26.83 | ||
High | $26.93 | ||
Low | $25.36 | ||
Previous Close | $26.49 | ||
Volume | 1,068,341 | ||
30-Day Average Volume | 2,345,579 | ||
1-Week Change | 1.67% | ||
1-Month Change | -25.64% | ||
1-Year Change | 35.53% | ||
3-Year Change | -17.33% | ||
5-Year Change | -72.26% | ||
Fundamentals | |||
Shares Outstanding | 102.9M | ||
Total Assets | $1.5B | ||
Market Cap | $2.6B | ||
Enterprise Value | $2.4B | ||
Period: QTR TTM FY | |||
Revenue | $31.7M | ||
Net Income | -$94.3M | ||
Free Cash Flow | -$130.7M | ||
EBIT | -$93.3M | ||
EBITDA | -$87.7M | ||
Net Working Capital | $1.2B | ||
EPS | -$0.91 | ||
Enterprise Value/EBITDA | -28 | ||
Enterprise Value/Revenue | 77 | ||
P/B | 2 | ||
P/E | -28 | ||
PEG | 0 | ||
Price/Free Cash Flow | -20 | ||
Price/Operating Cash Flow | -20 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 02/04/2014 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue